drugset / Trial / NCT01095913
Fluorescent Dyes for Lymph Node Mapping
Phase 1
Completed
30 enrolled
M.D. Anderson Cancer Center
American Cancer Society, Inc. · collabNational Cancer Institute (NCI) · collabThe University of Texas Health Science Center, Houston · collab
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to find lymph nodes before surgery using a dye called indocyanine green (IC-Green). Objectives: 1. To determine the feasibility of using nonradioactive optical imaging techniques with indocyanine green (ICG) as a fluorescent contrast agent to identify all axillary lymph nodes. 2. To determine the feasibility of using nonradioactive optical imaging techniques with ICG as a fluorescent contrast agent to characterize lymphatic architecture and function in women with breast cancer who are scheduled for axillary node dissection.
Timeline
- Start
- 2010-03
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indocyanine Green | Diagnostic / imaging agent | 25 ug | — |